Parkinson DiseaseNCT05011175
Exercise Habits: A Survey of Individuals With Parkinson's Disease Living in the Community
An observational study of Parkinson Disease, run by Jordana Lockwich at 1 site in United States.
Trial summary
This study aims to evaluate the exercise regimens of individuals with Parkinson's. Read more about this study
- Who is it for?
- Ages 40 to 90 yearsHealthy volunteers can take part
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- Survey
- How many people
- 138 participants
- Where
- 1 siteUnited States
- Study dates
- 1 May 2020to 30 Sep 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 90 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Individuals ages 40-90 years old who have been diagnosed with Parkinson's Disease.
Who may be able to join
- Diagnosed with Parkinson's Disease
- Able to speak English
Who cannot join
- No internet access
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to evaluate the exercise regimens of individuals with Parkinson's.
- Conditions
- Parkinson Disease
- Being tested
- Survey
- Keywords
- Exercise, Survey
- Medical subject headings
- Parkinson Disease, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
Participants responded to questions about their exercise habits and perceived levels of intensity as well as demographic information.
| Study group | Role | What they receive |
|---|---|---|
| Individuals with Parkinson's Disease | Individuals that have been diagnosed with Parkinson's Disease will be enrolled to participant in the survey research. Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Age
Average age of participants enrolled
Measured: Reported at baseline
Self-reported age of Parkinson's Disease Diagnosis
Average age of diagnosis with Parkinson's Disease for enrolled participants.
Measured: Reported at baseline
Self-reported education level
Number of participants reporting 1. less than 12 years of school, 2. completed high school, 3. completed bachelor degree, 4. completed graduate/advanced degree.
Measured: Reported at baseline
Self-reported living situation
Number of participants reporting 1.living alone, 2. living with others 3. living in a healthcare facility
Measured: Reported at baseline
Self-reported number of years taking medicine for Parkinson's Disease
Average number of years participants reported taking medication for Parkinson's Disease
Measured: Reported at baseline
Self-reported brain stimulation treatment
Number of participants reporting they have undergone deep brain stimulation for Parkinson's Disease.
Measured: Reported at baseline
Self-reported stage of Parkinson's Disease
Average reported stage of Parkinson's Disease participants (1. mild with no symptoms, 2. mild with symptoms, 3. moderate, 4. advanced, able to walk 5. advanced, unable to walk).
Measured: Reported at baseline
Self-reported physical help requirement
Number of participants reporting 1. they need help from another person during the day or 2. they do not need help from another person during the day.
Measured: Reported at baseline
Self-reported walking ability
Number of participants reporting 1. ability to walk unaided, 2. ability to walk with an assistive device, or 3. requiring assistance to walk
Measured: Reported at baseline
Self-reported mobility level
Participants reported mobility level ranging from independent to total assist required.
Measured: Reported at baseline
Self-reported current exercise habits survey
3 question survey component evaluating the exercise habits of individuals with Parkinson's Disease using a Likert scale from 0-5 where 5 indicated a higher levels of exercise.
Measured: Reported at baseline
Perceived levels of intensity
7 question survey evaluating the level of intensity of exercise of individuals with Parkinson's Disease using a Likert scale from 0-5 where 5 indicated higher levels of intensity.
Measured: Reported at baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Aug 2021
- Study start1 May 2020
- Primary completion30 Sep 2020
- Study completion30 Sep 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 138 participants (actual)
Sponsor and investigators
- Lead sponsor
- Jordana Lockwich
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Jordana Lockwich, University of Kentucky
- Investigators
- Jordana Lockwich, PT, DPT, Principal investigator, University of Kentucky
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05011175
- Sponsor's protocol ID
- 59258
- Status last verified
- Aug 2021
- First submitted
- 16 Aug 2021
- Last updated
- 18 Aug 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Aug 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exercise Habits: A Survey of Individuals With Parkinson's Disease Living in the Community
- ClinicalTrials.gov ID
- NCT05011175
- Acronym / sponsor ID
- 59258
- Conditions
- Parkinson Disease
- Keywords
- Exercise, Survey
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 138 participants (actual)
- Lead sponsor
- Jordana LockwichUniversity, hospital or other
- Study start
- 1 May 2020 (actual)
- Primary completion
- 30 Sep 2020 (actual)
- Study completion
- 30 Sep 2020 (actual)
- First posted
- 18 Aug 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the exercise regimens of individuals with Parkinson's.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Individuals with Parkinson's Disease | – | Other: SurveyIndividuals that have been diagnosed with Parkinson's Disease will be enrolled to participant in the survey research. |
Who may qualify
- Ages
- 40 to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Individuals ages 40-90 years old who have been diagnosed with Parkinson's Disease.
Key inclusion criteria (2 listed)
- Diagnosed with Parkinson's Disease
- Able to speak English
Key exclusion criteria (1 listed)
- No internet access
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyParticipants responded to questions about their exercise habits and perceived levels of intensity as well as demographic information. | Other | Individuals with Parkinson's Disease |
Primary outcome
Age
Time frame: Reported at baseline
Average age of participants enrolled
Self-reported age of Parkinson's Disease Diagnosis
Time frame: Reported at baseline
Average age of diagnosis with Parkinson's Disease for enrolled participants.
Self-reported education level
Time frame: Reported at baseline
Number of participants reporting 1. less than 12 years of school, 2. completed high school, 3. completed bachelor degree, 4. completed graduate/advanced degree.
Self-reported living situation
Time frame: Reported at baseline
Number of participants reporting 1.living alone, 2. living with others 3. living in a healthcare facility
Self-reported number of years taking medicine for Parkinson's Disease
Time frame: Reported at baseline
Average number of years participants reported taking medication for Parkinson's Disease
Self-reported brain stimulation treatment
Time frame: Reported at baseline
Number of participants reporting they have undergone deep brain stimulation for Parkinson's Disease.
Self-reported stage of Parkinson's Disease
Time frame: Reported at baseline
Average reported stage of Parkinson's Disease participants (1. mild with no symptoms, 2. mild with symptoms, 3. moderate, 4. advanced, able to walk 5. advanced, unable to walk).
Self-reported physical help requirement
Time frame: Reported at baseline
Number of participants reporting 1. they need help from another person during the day or 2. they do not need help from another person during the day.
Self-reported walking ability
Time frame: Reported at baseline
Number of participants reporting 1. ability to walk unaided, 2. ability to walk with an assistive device, or 3. requiring assistance to walk
Self-reported mobility level
Time frame: Reported at baseline
Participants reported mobility level ranging from independent to total assist required.
Self-reported current exercise habits survey
Time frame: Reported at baseline
3 question survey component evaluating the exercise habits of individuals with Parkinson's Disease using a Likert scale from 0-5 where 5 indicated a higher levels of exercise.
Perceived levels of intensity
Time frame: Reported at baseline
7 question survey evaluating the level of intensity of exercise of individuals with Parkinson's Disease using a Likert scale from 0-5 where 5 indicated higher levels of intensity.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Aug 2021.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jordana Lockwich, PT, DPT principal investigator
University of Kentucky
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Parkinson Disease, run by Jordana Lockwich at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Age (time frame: Reported at baseline). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2021.